spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Esprit Pharma 

 HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Sep 2008
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 27 Mar 2008
EKR Therapeutics Announces Management Additions and Promotions, Reflecting Support of Continued Acceleration in Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2007
Allergan Announces Completion of Esprit Pharma Acquisition
Biopharmaceuticals Urology Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2007
Esprit Pharma Secures Marketing Rights to SANCTURA(R) XR Creating a New Benchmark for Tolerability in the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing
 HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Apr 2007
Indevus and Valera Announce Completion of Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 26 Mar 2007
Indevus Reports That Interim Review of NEBIDO(R) Phase III Data Indicates Trial Is Likely to Meet Primary Endpoints
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 4 Jan 2007
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
Biopharmaceuticals
 HSMN NewsFeed - 21 Dec 2006
Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
Biopharmaceuticals Licensing Litigation
 HSMN NewsFeed - 18 Dec 2006
Depomed Delivers Notice of Breach and Demand for Arbitration to Esprit Pharma
Biopharmaceuticals Drug Delivery Litigation
 HSMN NewsFeed - 13 Dec 2006
Novavax Relocating Corporate Headquarters to Maryland
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2006
FDA Accepts New Drug Application for SANCTURA XR(TM) Submitted by Indevus
Biopharmaceuticals Urology
 HSMN NewsFeed - 6 Nov 2006
Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Madaus GmbH
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Oct 2006
Indevus Announces Submission of New Drug Application Seeking Approval for SANCTURA XR to Treat Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 26 Sep 2006
Patrick G. LePore Named President and Chief Executive Officer of Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2006
EKR Therapeutics Expands Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Aug 2006
Esprit Pharma Successfully Completes a Series B Financing, Raising in Excess of $90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jun 2006
Indevus Announces Positive Phase III Data for SANCTURA XR(TM)
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 May 2006
Esprit Pharma Acquires Exclusive North American Rights to a Novel Treatment for Hypoactive Sexual Desire Disorder in Women from Novavax
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2006
Esprit Pharma Appoints Vice President of Trade
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2006
Depomed and Madaus S.r.l. Announce Acceptance of the Application for Approval of ProQuin(R) XR in Sweden
Biopharmaceuticals Regulatory
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
Esprit Pharma
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.